Indefinite Delivery Contract SPE2DX17D9788

The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DX program, has an ultimate completion date of November 30, 2024 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products span various categories such as injections, tablets, creams, auto-injectors, and specialty medications to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. Through this IDC, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA, positioning the company as a crucial supplier in the federal pharmaceutical supply chain.